Anti-Nephrin Antibodies in Minimal Change Disease
Approach to the Patient with Peritoneal Dialysis Catheter Dysfunction- Part 1
Want to write a case report? RFN has you covered with a list of journals to choose from
Have a Nephrology Question? There Might Be A #Tweetorial For That!
Conferences, Courses, & Grants
FOAMed
Interventional Nephrology Series
Focus on Point-of-Care Ultrasound in Nephrology (POCUN) Series
Kidney Biopsy of the Month Series
Hyponatremia Guidelines – NephJC
Tomorrow night will be the 4th edition of the Nephrology Journal Club on twitter.The article this week is unusual – it is a clinical practice guideline for the management of hyponatremia that was published in NDT, the European…
Deceased Donor Kidney Allocation 2014
In the USA in June 2013 the OPTN/UNOS Board of Directors approved amendments to the OPTN policy for deceased donor kidney allocation. These ideas have been discussed for the last 9 years and Nate wrote about some of…
Bedside Urinalysis – Blood
All to often now doctors in well-resourced hospitals rely on high tech, expensive and sometimes invasive tests to make a diagnosis. One of the most basic and cheapest tools we have at our disposal is the bedside urine…
SGLT-2 and the genesis of hyperfiltration
Over at eAJKD, Swapnil Hiremath has a nice post about the potential for SGLT-2 inhibitors to prevent diabetic nephropathy based on a review article published on the topic in AJKD. Essentially the theory is that increased serum glucose…
The use of IVIg in Kidney Disease
It’s time for a quick nephro-centric summary of immune globulin use. Immune globulin, usually administered intravenously (IVIg), is made from pooled human plasma and used for a wide variety of human disease. It contains mostly IgG with various…
Endothelin Antagonism for Diabetic Nephropathy: Nephrology Twitter Journal Club
The next Nephrology Twitter Journal Club (@NephJC) will discuss a study in JASN describing the use of Atrasentan, a selective Endothelin-A receptor blocker, in diabetic kidney disease. This is the latest attempt to resurrect this class of agents…
Nephrology Twitter Journal Club (#NephJC): CKD Screening & Education
The inaugural Nephrology Twitter Journal Club kicks off tomorrow evening, that’s Tuesday April 29th, at 9pm Eastern time. The article being discussed concerns the implementation of a kidney disease screening and education program and its impact on ESRD…
The ongoing debate about the definition of CKD in the elderly
In NDT this month, there is a nice series of articles outlining the ongoing debate about whether or not an eGFR<60 should be considered a disease, particularly in the elderly. The pro side was argued by Giuseppe Conte…
Hepatitis C cure on the Horizon: Implications for Nephrology
You have probably noticed the flurry of articles published this week in the NEJM, coinciding with the International Liver Congress meeting in London, reporting incredible results with new direct-acting antiviral agents in Hepatitis C. This is undoubtedly one…
The use of Rituximab in Kidney Disease
Rituximab, the monoclonal chimeric anti-CD20 antibody, is an effective B-Cell depleting agent and continues to gather data for its use in a wide range of conditions relevant for the Nephrologist. It was also a pre-season favourite in the…